In a recent legal tussle that put Apple’s latest smartwatches in the spotlight, the tech giant found itself embroiled in a patent dispute with medical technology company Masimo, resulting in a ban on the sale of Apple Watches in the US that featured SpO2 (blood oxygen level) sensors. This ban significantly impacted the availability of Apple’s Watch Series 9 and Watch Ultra 2, compelling Apple to pull these models from both online and offline stores.
However, Apple swiftly appealed against the ban, seeking a temporary halt in the US Court of Appeals for the Federal Circuit. The aim was to pause the ban until the US Customs could assess whether alterations made to the Apple Watch could potentially resolve the ongoing dispute with Masimo.
Fortunately for Apple, the appeals court granted the request for a temporary halt on the ban. This reprieve allows Apple to resume the sales of its latest watches through its stores until the next crucial hearing scheduled for January 12, 2024.
During the ban period, third-party retailers were permitted to continue selling the affected Apple Watch models until their existing stocks were depleted. But with this temporary stay, Apple regains the opportunity to offer its latest wearable technology directly to consumers while awaiting the court’s next decision.
The upcoming hearing on January 12 could sway the trajectory of this legal saga. Depending on the court’s ruling, the stay on the ban might be extended, allowing Apple to continue the sale of its watches for a more extended period. Conversely, a ruling against Apple by the US Customs could reimpose the sales ban, preventing the Cupertino-based company from distributing smartwatches equipped with SpO2 sensors.
The tech community, along with consumers, now holds its breath, eagerly awaiting the outcome of this legal battle. Apple’s fortunes in the smartwatch market hinge on the forthcoming decision, which could shape the availability and future of its latest wearable offerings. As the January 12 hearing approaches, all eyes remain on the courtroom, waiting to see how this chapter unfolds for Apple and its popular line of smartwatches.
